⌘K

Home/Filings/4/0001104659-23-129364

4//SEC Filing

Odysseas Kostas D 4

Accession 0001104659-23-129364

CIK 0000921114other

View on SEC.gov Company Profile

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 9:53 PM ET

Size

5.6 KB

Accession

0001104659-23-129364

Insider Transaction Report

Form 4

Period: 2023-12-21

Armata Pharmaceuticals, Inc.ARMP

Kostas Odysseas D

Director

Transactions

Award
Stock Options (Right to Buy)
2023-12-21+10,461→ 10,461 total
Exercise: $2.39Exp: 2033-12-21→ Common Stock (10,461 underlying)

Footnotes (1)

[F1]The stock option vests immediately prior to the Company's 2024 annual shareholders meeting.

Documents

1 file

4
tm2333426-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Armata Pharmaceuticals, Inc.

CIK 0000921114

Entity typeother

Related Parties

1

filerCIK 0001483080

Filing Metadata

Form type: 4
Filed: Dec 25, 7:00 PM ET
Accepted: Dec 26, 9:53 PM ET
Size: 5.6 KB

View on SEC.gov